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Tube feedingProlonged enteral or parenteral nutrition in neonatal periods sometimes results in eating difﬁculties persisting
for years, with reduced food intake through the oral route and thereby reduced stimulation of the oral cavity.
Aiming at describing the consequences on oral physiology, saliva of 21 children with eating difﬁculties (ED)
was compared to that of 23 healthy controls, using various omics and targetedmethods. Overall, despite hetero-
geneity within the groups (age, medication etc.), the three spectral methods (MALDI–TOF, SELDI–TOF, 1H NMR)
allowed discriminating ED and controls, conﬁrming that oral stimulation by food intake plays a role in shaping
the composition of saliva. Saliva of ED patients exhibited a lower antioxidant status and lower levels of the
salivary protease inhibitors cystatins. Other discriminant features (IgA1, dimethylamine) may relate to modiﬁed
oral and/or intestinal microbial ecology. Finally, salivary proﬁles of ED patients were partly comparable to those
of subjects with exacerbated gustatory sensitivities, in particular with reduced abundance of cystatin SN and
higher abundance of zinc-alpha-2-glycoprotein. Whether this translates taste hypersensitivity and contributes
to the eating difﬁculties deserves further attention.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Enteral nutrition through a nasogastric tube or a gastrotomy, or even
total parenteral nutrition, is sometimes required as part of pediatric
medical care. Tube feeding is for example used in premature babies
who have not fully developed feeding skills, in particular appropriate
coordination of sucking/swallowing and breathing ormuscular strength
and coordination to ensure safe swallowing [1]. Artiﬁcial nutrition can
also be needed in children affected by a variety of medical conditions
(e.g. heart disease, renal failure, intestinal malabsorption…) while
they are receiving medical treatment. Although tube feeding has some
obvious and immediate beneﬁts from a nutrition point of view, some
children develop feeding difﬁculties when weaning from the tube isdes Sciences du Goût et de
zel).attempted. For example, the case of 9 infants aged 3–14 months, who
had never received oral feeding since birth was reported. Regardless
of confounding comorbidities, it was described that most of those
infants had an exacerbated gag reﬂex and deﬁcient sucking abilities
[2]. The authors also suggested that the time necessary to resume full
oral feeding increased with the duration of tube feeding. This was
conﬁrmed by another study [3] which compared the feeding skills at
11 and 17 months corrected age of pre-term vs full-term infants. Pre-
term infants who had received nasogastric feeding for more than
3 weeks exhibited an increased oral sensitivity (translated for example
by facial defensive behavior to approaching contact with the lips and
mouth) and delayed feeding development in comparison to full-term
infants but also compared to pre-term infants who had received naso-
gastric feeding for less than two weeks. This study also evidenced that
feeding difﬁculties can persist for prolonged periods. Similarly, in a
review of 100 infants fed by nasogastric and gastrotomy tubes within
their ﬁrst 6 months of life, the transition from tube to oral feeding was
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proportion (6%) of children [4]. Altogether, tube feeding in the neonatal
period, especially when it is prolonged and associated to medical com-
plications, may sometimes result in the need of constant or intermittent
nutritional support for years. This has for consequences reduced food
intake through the oral route and lower sensory stimulation of the
oral cavity.
Sensory stimulation of the oral cavity is known to affect salivaryﬂow
and composition. In particular, taste and trigeminal stimulations have
an immediate effect on saliva ﬂow [5–7], and the composition in pro-
teins has also been reported to be modiﬁed by exposure to compounds
eliciting a taste or trigeminal sensation [8–11]. Besides this reﬂex
response, the plasticity of saliva composition according to diet has
been suggested. For example, in a 1970 review considering both animal
and human studies [12], the consistency (liquid vs solid) of nutritionally
equivalent meals was reported to have an impact on saliva ﬂow which
highlights the importance of mechanical stimulation of the oral cavity
on salivary glands' secretion. In addition, salivary parameters may also
be linked to sensory acceptance of foods in humans, as suggested by
the positive associations between saliva composition and fat liking
[13] or between salivary protein proﬁles and acceptance of bitterness
in infants [14].
The present study focuses on children who have received artiﬁcial
nutrition in their neonatal period and who have developed long-term
feeding difﬁculties resulting in limited amount of energy intake through
the oral route. Given this reduced stimulation of the oral cavity, and the
role that saliva may play in ingestive behavior, this proof-of-concept
study aimed at describing the consequences of such diets on saliva
composition. Complementary “omics” methods covering a range of
expression products (proteins, peptides, metabolites) were used, as
well as targeted methods (protein content, enzymatic activities, antiox-
idant status).
2. Materials and methods
2.1. Study subjects
The study was approved by the local ethical committee (Comité de
Protection des Personnes Sud-Est II, n° 2011-039-2) and by the Direc-
tion Générale de la Santé (AFFSAPS, n° B111079-90). Written informed
consent was obtained from the children's parents. The study included
21 children (12 females, 9 males) who had developed eating difﬁculties
consecutively to receiving artiﬁcial nutrition in the neonatal period.
More speciﬁcally, the criterion of inclusion was that patients had
received nutritional support for at least 3 months within the 6 months
period following birth. At the time of sampling, the patients were aged
between 22 and 89 months (median value 4.8 years) and were still
fed via the enteral or parenteral route to a minimum level of 50% of
their total energy intake. Dental examinations revealed that three
patients displayed tartar build-ups. The study also included 23 healthy
children (11 females, 12 males) aged between 22 and 136 months
(median value 5.3 years) as controls. No abnormalities were detected
with regards to their dental status. The two groups were age-matched
by age classes (up to 5 year-old, 6–11 year-old). Patientswith eating dif-
ﬁculties are designated below as “ED” and healthy controls as “C”.
2.2. Saliva sampling
Salivawas sampled at the time of inclusion (T0), and again 6months
(T6) and 12 months (T12) afterwards. Sampling was performed by
aspiration of saliva on the ﬂoor of the mouth through a soft catheter.
Saliva was collected in a plastic tube placed on ice. Aspiration lasted
for 5 min, or for a shorter period in case of discomfort. Within 30 min
after sampling, saliva was centrifuged at 10,000 g for 15 min at 4 °C
and the supernatant was aliquoted. Aliquots were stored at −80 °C
until analyses.2.3. Targeted biochemical analyses
All enzyme activities were expressed in milli International Enzyme
Activity Units (IU) per ml of saliva. One IU is deﬁned as the amount of
enzyme that catalyzes the conversion of 1 μmol of substrate perminute.
Protein concentration (mg.ml−1) was measured with a Quick Start
Bradford protein assay (Bio-Rad, France) with bovine serum albumin
as the calibration standard.
2.3.1. Amylolysis
Amylase activity was determined using the amylase CNPG3 assay kit
(Biolabo France). 2-chloro-4-nitrophenyl malto trioside (CNPG3) is
converted in CNP (Chloro-nitro-phenol) by salivary amylase during in-
cubation with saliva samples at 37 °C. Kinetics of absorbance at 405 nm
was performed at 37 °C using a microplate spectrophotometer (Victor
3-V, PerkinElmer, France). The initial rate of reaction is compared to a
standard to determine samples amylase activity. The standard curve
was established using quality control serum Extratol-N (Biolabo).
2.3.2. Lipolysis
Lipolysis was adapted from the method described in Neyraud
et al. [13]. A 20 mM substrate solution was prepared from 4-
methylumbelliferyl-7-oleate (Sigma–Aldrich, France) in ethanol,
and it was diluted to 1 mM in a buffer containing 20 mM Tris–HCl,
pH 7.5, 4 mM CaCl2, 2 mM EDTA, 0.2% (w/v) NaTDC (sodium
taurodeoxycholate), 1 mM PMSF (phenylmethylsulphonyl ﬂuoride),
1mMDTT and 0.02% (w/v) sodium azide. The reactionwas started by
adding 37.5 μl of saliva to 150 μl of 1 mM substrate solution and 1.5 μl
ethanol. An inhibition reaction was also performed on each sample by
adding 1.5 μl of a 56mMethanolic solution of THL (tetrahydrolipstatin)
instead of ethanol. Kinetics of the intensity of ﬂuorescence was record-
ed at 37 °C (excitation ﬁlter: 355 nm; emission ﬁlter: 460 nm) using a
microplate ﬂuorometer (Victor 3-V, PerkinElmer, France). Lipolysis
was calculated from the difference of ﬂuorescence slope of each sample
with andwithout THL and expressed in reference to a standard curve of
umbelliferone. At each set of measurements, a control of the linearity
and proportionality of the reaction was performed using commercial li-
pase (Aspergillus niger Lipase, Fluka, France).
2.3.3. Proteolysis
Proteolysis was determined using a Pierce Fluorescent Assay Kit
(Pierce Biotechnology, Rockford, IL) following themanufacturer's instruc-
tions. This kit uses a ﬂuorescein-labeled casein substrate which emits
ﬂuorescence upon proteolytic digestion (excitation at 494 nm/emission
at 518 nm). Tryspin was used to establish a standard curve. Results
were obtained as trypsin equivalent and further converted into IU.
2.3.4. Total antioxidant status
Total antioxidant status was determined using an ORAC Assay kit
(Zen-Bio, Research Triangle Park, NC, USA). This assay uses the free rad-
icals initiator AAPH (2,2′-azobis-2-methyl-propanimidamide, dihydro-
chloride). Peroxyl radicals then oxidize ﬂuorescein with a consequent
loss of ﬂuorescence. Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-
2-carboxylic acid), a water-soluble vitamin E analogue, serves as a stan-
dard to inhibit ﬂuorescein decay in a dose dependent manner. Kinetics
of the intensity of ﬂuorescence was recorded at 37 °C (excitation ﬁlter:
485 nm; emission ﬁlter: 538 nm) using a microplate ﬂuorometer
(Victor 3-V, PerkinElmer, France). The antioxidant capacity of saliva
was expressed as micromolar Trolox equivalents per ml.
2.4. Proteome analysis
2.4.1. 2D electrophoresis and identiﬁcation of proteins of interest by
MALDI–ToF–ToF
Sample preparation and 2D electrophoresis were performed follow-
ing the protocol previously used for saliva and described in Mounayar
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11 cm 3-10NL IEF strip was adjusted to 100 μg. Two strips were placed
adjacently on one large second dimension gel. Strips were randomly
assigned to gels. Gel images were acquired on a GS-800 densitometer
(Bio-Rad) and images were analyzed using Samespots software (Non-
Linear Dynamics). 163 spots were detected and matched across all
gels. Spot volumes were normalized within one gel and transformed
into log values. Following statistical analysis, spots of interest were
manually excised. Spot preparation, trypsin digestion, peptide extrac-
tion and MALDI–TOF MS and MS–MS analyses using a MALDI TOF/TOF
UltraﬂeXtreme were performed as in Mounayar et al. [16]. For one
spot in particular containing cystatin B, and based on the fact that this
protein is detected in human saliva mostly as S-modiﬁed N-acetylated
derivatives [17,18], N-acetylation, glutathionylation and cysteinylation
were accepted as variable modiﬁcations in order to tentatively identify
the proteoform involved. The database search was performed in
SwissProt restricted to human entries.
2.4.2. SELDI–ToF MS proﬁling
For SELDI–TOF analysis, 25 μl of saliva were diluted with 225 μL of
dilution buffer (0.5 M NaCl, 0.1% Triton in PBS). The ProteinChip arrays
were conditioned in the following manner: 5 μl of 100 mM copper
sulfate were loaded onto the spots. After 5 min incubation in a wet
chamber, the CuSO4 solution was removed and arrays were washed
twice with 10 μl of water. Arrays were then pre-equilibrated with
150 μL of dilution buffer for 5 min with gentle agitation. After removing
buffer, diluted samples were added and incubated for 45 min on a plate
shaker at room temperature. The wells were washed with 200 μL of
dilution buffer (2 × 5 min) and 200 μL of dilution buffer without triton
(1 × 5 min), and ﬁnally brieﬂy rinsed with water. ProteinChip arrays
were air-dried. Finally, 0.8 μL of saturated sinapinic acid solution was
applied twice to each spot and the chips were allowed to air-dry
again. Mass spectrometry analyses were performed in a PCS4000
ProteinChip reader (Bio-Rad). Two calibrations were performed.
For the low mass range (LMW), data were collected between 2 and
20 kDa, with a focusing mass at 10 kDa and a laser intensity set at
2400. For the highmass range (HMW), the datawere collected between
20 and 200 kDa, with a focusing mass at 50 kDa and a laser intensity set
at 2600. Each spectrumwas the result of 530 laser shots and was exter-
nally calibrated. Spectra analysis was carried out using the ProteinChip
Data manager 3.5 (Bio-Rad). Peaks with a ratio signal/noise above 3
were identiﬁed by the ProteinChip Software. In total, 74 m/z peaks
were retained and quantiﬁed in all samples.
2.4.3. Quantiﬁcation of cystatin SN by ELISA
Cystatin SN was quantiﬁed using an Enzyme-Linked Immunosor-
bent Assay kit from Cusabio (Cusabio, Wuhan, China) following the
manufacturer's instructions. The concentrations were obtained in
ng/ml.
2.5. Peptidome proﬁling by label-free MALDI–ToF
Peptide extracts for MALDI–TOF proﬁling were prepared by ultra-
ﬁltration with a molecular weight cut-off of 5 kDa. 1 μl of sample was
loaded on a ground steel target. Each spot was then covered with 1 μl
of HCCA solution (3 mg.ml−1 in 50% ACN, 2% TFA) and dried at room
temperature. Four technical replicates were performed. Samples were
then automatically analyzed in linear positive mode using a MALDI–
TOF mass spectrometer (Autoﬂex, Bruker) in the m/z range 0–3000.
The 330 resulting spectra were ﬁrst pre-processed to retrieve from the
observed signals the part related to technical noise (removal of random
noise of measure, baseline subtraction, normalization). Peaks corre-
sponding to potential markers (295 per subject) were then detected
and quantiﬁed.
Following statistical analysis (described below), identiﬁcation of dis-
criminant peaks was attempted by MALDI–TOF–TOF and nanoLC–ESIMS–MS. For MALDI–TOF–TOF, an UltraﬂeXtreme Bruker Daltonics
mass spectrometer was used in automatic mode. Ionization was per-
formed by irradiation of a nitrogen laser (337 nm) operating at 1 GHz
in reﬂector mode. Mass calibration was achieved using the peptide
calibration standards from Bruker Daltonics. MS–MS spectra were
interpreted with the MatrixScience MASCOT search engine against the
SwissProt database. Methionine oxidation was accepted as a variable
modiﬁcation. Mass deviation tolerance was set at 50 ppm in MS mode
and 0.6 Da in MS/MS mode. For nanoLC–ESI MS–MS, liquid chromatog-
raphy was performed on a C18 column (15 cm, 75 μm of internal
diameter) with a gradient consisting of 2–80% ACN in 0.1% formic acid
over 1 h. The eluate was directed to an Orbitrap mass spectrometer
(ELITE, ThermoScientiﬁc). For each full MS scan, MS–MS spectra were
obtained for the 20 most abundant peaks. Raw data were processed
and identiﬁcation was performed using the software Proteome Discov-
erer 1.4, searching the SwissProt database. Methionine was accepted
as a variable modiﬁcation. Peptide mass tolerance and fragment mass
tolerance were set at 10 ppm and 0.6 Da, respectively.
2.6. Metabolome analysis by 1H NMR
1H-NMR analyses on saliva samples were performed according to
the protocol described in Neyraud et al. [19]. 100 μl of sample were
mixed to 550 μl of deuterium oxide (D2O) containing 0.25 mM sodium
trimethylsilyl-[2,2,3,3-2H4]-1-propionate (TSP; as a chemical shift refer-
ence at 0 ppm). After centrifugation (10 min at 5,000 ×g), the super-
natant was introduced in a 5 mm NMR tube. Spectra were obtained
using a Bruker DRX-600 Advance NMR spectrometer operating at
600.13 MHz for a 1H resonance frequency and an inverse detection
5 mm 1H–13C–15N cryoprobe attached to a cryoplatform. A total of 512
transients were acquired at 300 K using the Carr–Purcell–Meiboom–
Gill (CPMG) spin-echo pulse sequence with presaturation. Spectra
were data reduced using AMIX (version 3.9.11, Bruker, Germany) to
integrate 0.01 ppm wide regions corresponding to the δ 8.5–0.7 ppm
region. The δ 6.7–4.25 ppm region, which includes water resonance,
was excluded. Each integrated region was normalized to the total spec-
tral area. A total of 536 NMRbucketswere included in the datamatrices.
Following statistical analysis (described below), discriminant buckets
were assigned to metabolites using reference spectra from a home-
made and other reference databases (http://www.bmrb.wisc.edu/
metabolomics; http://www.hmdb.ca) and reports from literature.
2.7. Overview of analyses
Targeted analyses (n= 42, 20ED/22C), 2D electrophoresis (n = 26,
9ED/17C) and conﬁrmation of cystatin SN abundance by ELISA (n= 34,
15ED/19C) were performed on T0 samples taken at the ﬁrst sampling
time.
Proﬁling methods were performed on samples taken at the three
sampling times. The volume of saliva collected allowed performing the
following analyses: 1HNMR andMALDI-TOFMS analyses on 44 T0 sam-
ples, 33 T6 samples (16ED/17C) and 34 T12 samples (16ED/18C);
SELDI–TOF proﬁling on 42 T0 samples (20ED/22C), 33 T6 samples
(16ED/17C) and 33 T12 samples (16ED/17C).
2.8. Statistics
The difference between ED and C subjects in terms of saliva protein
content, TAS, enzymatic activities and 2DE protein spot abundance was
tested by Student-tests. Conﬁrmation of under-expression of cystatin
SN in ED subjectswas statistically tested using a one-tailed Student-test.
For spectral data (SELDI–TOF, MALDI–TOF, 1H NMR), the longitudi-
nal effect was evaluated by testing the correlation between datasets ob-
tained for each of the 3 sampling times. For this, RV coefﬁcients were
calculated and their signiﬁcance tested. The resulting p-values were all
b0.001, which indicates that spectra were overall not affected by the
Table 1
Biochemical characteristics of saliva of eating difﬁculties patients (ED, n=20) andhealthy
controls (C, n = 22).
Mean Median p-Value
ED C ED C
Protein content (mg.ml−1) 0.86 1.05 0.76 1.00 0.226
Amylolysis (mIU.ml−1) 84.53 117.86 47.39 81.13 0.146
Lipolysis (mIU.ml−1) 0.25 0.22 0.16 0.19 0.673
Proteolysis (mIU.ml−1) 122.38 22.98 11.12 7.27 0.075
TAS (μmol Trolox eq. ml−1) 33.27 62.30 26.70 52.11 b0.001
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Nevertheless, in order to account for the possibility that some speciﬁc
peaks may be affected, data were ﬁrst corrected for the “sampling
time effect” before retaining the median value of peak intensities over
the 3 sampling times. A Surrogate Variables Analysis was then per-
formed to select peaks discriminant between ED and C children. This
method allows the estimation and incorporation of known as well as
unknown sources of variability that may be confounding. Differential
markers are selected based on the signiﬁcance of their differential effect.
Benjamini–Hochberg correction method was applied to control the
False Discovery Rate (FDR) at 10%.
Finally, the impact of age on abundance of the discriminant features
was tested. For each discriminant variable, a linear model (abundance
vs age of the subjects at T0) was adjusted and its signiﬁcance tested
by ANOVA.
3. Results
3.1. Targeted biochemical analyses
Protein content, lipolytic activity and amylolytic activity were not
signiﬁcant different between the two groups. There was a tendency
(p = 0.075) for proteolytic activity to be higher in ED patients, and
they also exhibited a signiﬁcant (p b 0.001) lower total antioxidant
status (Table 1).
3.2. Proteome analysis
The expression level of 11 spots was signiﬁcantly (p b 0.05) different
between ED and C subjects, with 6 spots under-expressed and 5 over-
expressed in ED subjects. Ten out of the 11 spots were successfully
identiﬁed by MALDI–TOF MS–MS (Table 2). The identiﬁed proteins
showed apparent molecular weights close to the theoretical ones,Table 2
Details of mass spectrometry results (MALDI–TOF or MALDI TOF–TOF) for proteins differently
Protein Fold-
change
p Value SwissProt
reference
Theoreticala/estimated
MW (kDa)
Under-expressed i
Cystatin SN 1.9 b0.001 P01037 14.3/14
Cystatin D 2.5 0.003 P28325 13.9/13
Cystatin B 1.5 0.006 P04080 11.1/11
n.i. 2.2 0.022 / /
Cystatin D 1.8 0.030 P28325 13.9/13
Glutathione-S-transferase P 1.7 0.046 P09211 23.2/23
Over-expressed in
Alpha-amylase 1 1.8 0.002 P04745 55.9/30
Ig alpha-1 chain C region 1.9 0.025 P01876 37.7/35
Zinc-alpha-2-glycoprotein 1.7 0.027 P25311 34.3/32
Ig kappa chain V-II region TEW 1.5 0.029 P01617 12.1/27
Ig kappa chain C region P01834 11.6/27
Alpha-amylase 1 1.6 0.030 P04745 55.9/56
a The theoretical molecular weight reported is that of the mature chain.
b In MS mode, the identiﬁcation is signiﬁcant if Mascot score is N56.
c In MS/MS mode, the identiﬁcation is signiﬁcant if Mascot score is N50.with two exceptions. One spot containing alpha-amylase 1 appeared
at approximately 30 kDa, which indicates that the protein is truncated
by proteolysis or alternative splicing. Another spot containing both the
variable and constant regions of the immunoglobulin light chain
kappa appeared at a molecular weight corresponding approximately
to the sum of the individual regions' molecular weights, suggesting
that the spot contained a full Ig kappa. Concerning cystatin B, the spe-
ciﬁc proteoform could not be identiﬁed since the tryptic peptide that
would be modiﬁed (MMCGAPSATQPATAETQHIADQVR) was detected
neither as unmodiﬁed nor as N-acetylated or N-acetylated S-modiﬁed
derivatives (glutathionylated or cysteinylated). Other methods such as
top-downRP–HPLC–ESI–MSwould be of interest to further characterize
the exact cystatin B proteoform present in the differently expressed
spot, as previously reported [17]. Nevertheless, altogether, saliva of ED
patients was characterized by lower abundance of cystatins (SN, B and
D) and glutathione S-transferase P (GSTP). Oppositely, it contained
more of two alpha-amylase 1 isoforms and zinc-alpha-2-glycoprotein
(ZAG). The results on Ig kappa light chain and Ig alpha-1 chain C region
(the constant region of IgA1 heavy chain) can be considered together as
an indication of over-expression of IgA1 in saliva of ED patients.
In SELDI–TOF proﬁling, 10 peaks were signiﬁcantly different (FDR b
10%) between ED and C subjects, with one peak over-expressed and
nine under-expressed in ED patients (Table 3). Identiﬁcation of discrim-
inant peaks is not readily available in SELDI–TOFMS. However, based on
the known molecular weight of cystatin SN (14,312 Da for the mature
chain), and the convergence with 2D results, it is most likely that
the most discriminant peak corresponds to this protein. In addition,
double-charged ions are occasionally generated and detected by
SELDI–TOF MS [20]. The peak at m/z 7155 could therefore also corre-
spond to the same compound that would be detected as a double-
charged ion.
Because of this common ﬁnding between the two techniques,
cystatin SN under-expression in saliva of ED patients was veriﬁed by
ELISA. Saliva of ED and C subjects contained 119 and 225 ng.ml−1 of
cystatin SN, respectively, and the difference between the two groups
was highly signiﬁcant (p= 0.001). Fig. 1 illustrates the ﬁndings related
to cystatin SN expression in saliva of ED and C subjects.
3.3. Peptidome analysis
The abundance of 6 peaks was signiﬁcantly (FDR b 10%) different
between ED and C subjects, with 2 peaks under-expressed and 4 over-
expressed in ED subjects (Table 3). Examination of MALDI–TOF spectra
revealed that the peaks at m/z 2112.88, 2630.21, 2658.10 were difﬁcult
to isolate for identiﬁcation by MALDI TOF–TOF due to the presence ofexpressed between eating difﬁculties subjects (ED) and healthy controls.
N° of peptides
MS mode
Sequence
coverage
Mascot scoreb
MS mode
N° of peptides identiﬁed
MS/MS mode
Mascot scorec
MS/MS mode
n ED patients
10 68.8 168.0 1 72.6
/ / / 2 152.9
6 64.3 100.0 2 188.5
/ / / / /
/ / / 2 178.8
5 35.7 87.3 2 102.5
ED patients
9 23.5 110.0 2 101.5
8 35.4 125.0 2 174.6
12 48.3 173.0 2 66.4
/ / / 2 78.6
5 82.1 91.0 2 110.0
25 54.4 237.0 2 174.3
Fig. 1. Under-expression of cystatin SN in eating difﬁculties (ED) patients compared to
healthy controls (C), illustrated by: A) volume representation of the two-dimensional
electrophoresis spot containing cystatin SN. For each group (ED, C), the minimal and
maximal values are represented. B) SELDI peaks putatively identiﬁed as corresponding
to cystatin SN as double charged (m/z 7155) and single-charged (m/z 14306) ions; and
C) quantiﬁcation of cystatin SN by ELISA (mean ± SEM).
Table 3
Mass spectrometry peaks and 1H NMR buckets differently represented between eating
difﬁculties subjects (ED) and healthy controls.
Method m/z (SELDI), M + H+ (MALDI)
or chemical shift in ppm (NMR)
Status in ED
patientsa
Adjusted
p-Values
SELDI TOF MS 2107 − 0.078
2612 + 0.057
3289 − 0.024
7155 − 0.057
11,732 − 0.095
14,306 − 0.024
19,091 − 0.056
28,646 − 0.037
29,729 − 0.078
43,220 − 0.057
MALDI–TOF MS 1033.57 + 0.053
1161.63 − 0.081
1353.73 − 0.078
2112.88 + 0.053
2630.21 + 0.069
2658.10 + 0.053
1H NMR 1.335, 1.325 + 0.067
1.485, 1.475 + 0.042
2.735 − 0.067
3.495 − 0.007
3.945 − 0.013
4.125, 4.115 + 0.095
7.915 − 0.036
a The “+” and “−” signs indicate that the compound is respectively over-represented or
under-represented in ED patients.
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other peaks, and the peak at m/z 1033.57 was identiﬁed as a fragment
of salivary acidic proline-rich phosphoprotein 1/2 (accession number
P02810, peptide sequence GPPQQGGHQQ). Fig. 2 illustrates theﬁndings
related to this peptide. Using nanoLC ESI MS–MS, an additional peak
atm/z 1161.63was identiﬁed. It corresponded to a fragment of submax-
illary gland androgen-regulated protein (accession number P02814,
peptide sequence GRIPPPPPAPY).
3.4. Metabolome analysis
10 bucketswere signiﬁcantly (FDRb 10%)different in abundance be-
tween the two groups (Table 3). These corresponded to 5 metabolites:
lactate (1.335, 1.325, 4.125, 4.115) and alanine (1.485, 1.475) were
over-represented in saliva of ED patients while dimethylamine (2.735),
galactose (3.495, 3.945) and histidine (7.915) were under-represented
in the same patients.
3.5. Impact of age on abundance of discriminant variables
Globally, the total antioxidant status was not affected by age. Simi-
larly, none of the discriminant peaks, buckets or spots were correlated
with age of the children at the time of inclusion.
4. Discussion
The present study aimed at investigating whether eating difﬁculties
developed consecutively to artiﬁcial nutrition in the ﬁrst months of life
had consequences on saliva proﬁles. The hypothesis tested was that the
common trait to all patients, namely the reduced intake of food through
the oral route, had an impact sufﬁciently important to be detected
in spite of other sources of variability (age, medical condition etc.).
Overall, we found that saliva of ED patients showed indeed distinctive
characteristics.
In this study, the impact of age on salivary proﬁles appeared rather
limited at two levels: for a given subject over one year, and at the
group level in the approximate age range 2–11 year-old. One should
note however that the purpose of this study was not to explore agevariations, elsewhere described by other authors [21], and therefore
we tested the age effect only on discriminant variables. The fact that
cystatin SN abundance in particular is not signiﬁcantly affected by age
of the subjects contrasts with ﬁndings of another study [21] but may
be explained by the lower number of subjects here.
From a mere proﬁling point of view, it is interesting to note that the
three spectral methods allowed discriminating between the two
groups. The difference between saliva of ED and C subjects was there-
fore related to all types of constituents measured: proteins, peptides
and metabolites. Proﬁling methods have been previously used to dis-
criminate saliva of patients and healthy subjects. For example, SELDI–
TOF MS was used to search for biomarkers of Sjögren's syndrome [22]
or of oral squamous cell carcinoma [23]. 1H NMR proved useful to iden-
tify different metabolite signatures in children with and without caries
[24]. As to MALDI–TOF proﬁling, it was combined to magnetic bead
sample treatment and allowed to identify markers of periodontal
disease in subjects with or without orthodontic treatment [25]. In all
Fig. 2. Over-expression of a fragment of salivary acidic proline-rich phosphoprotein 1/2 (m/z 1033.57) in eating difﬁculties (ED) patients compared to healthy controls (C). A) Boxplots of
the log-intensities of the peak after preprocessing, for ED and C subjects. B) MS–MS spectrum of the peptide.
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nous clinical criteria, and gross medical confounding conditions were
excluded. In the present study, what the patients had in common at
the time of sampling was a proportion of energy intake received by
the oral route at or below 50%, but they were otherwise quite diverse
with regards to their medications, and initial pathology. The fact that
it was still possible to discriminate ED and C subjects suggests a major
role of diet and/or food intake through the oral route to shape the com-
positional pattern of saliva.
The impact of diet on saliva composition of human subjects has been
reported on several occasions. At a population level for example, indi-
viduals from population with high-starch diets have more copies of
the salivary amylase gene AMY1 than those from populations with
low-starch diets [26]. At an individual level, shift from a mixed to a
lactovegetarian diet modiﬁed some salivary characteristics such as its
sodium content or buffering capacity [27], while change from a milk-
based to a diversiﬁed diet in infants had an impact both on salivary pro-
tein [28] and peptide [29] proﬁles. Another study compared two groups
of subjects, controls or subjected to a dietary intervention from infancy,
whowere the followed for up to 16 years of age. Although some dietary
differences persisted between the two groups, in particular a higher
ﬁber intake in the intervention group, the analyzed salivary constituents
(calcium, phosphate, total proteins) did not differ between the groups.
However, ﬂow rate and buffering capacity were modiﬁed [30]. There
are some differences between the studies of Laine et al. and the present
study where we also compared two different groups. First, we used
untargeted and highly resolutive methods which allowed discriminat-
ing the groups, and which identiﬁed molecules which may not have
been otherwise tested. Second, our ED and C groups were clearly
contrasted in terms of diet. Rather than differences in energy and nutri-
ment intake, where potential deﬁcits were compensated in ED children
by artiﬁcial nutrition, the speciﬁcity of ED childrenwas rather a reducedstimulation of the oral cavity by food intake, and most likely lower
diversity in their food repertoire. Altogether, this suggests that saliva
plasticity induced by usual diet is governed partly by mechanisms
linking local oral stimulation to saliva secretion.
Looking now at the biological information brought about by the dis-
criminating molecules and biochemical characteristics, a ﬁrst promi-
nent ﬁnding is that saliva of ED children had a lower total antioxidant
status (TAS). Many compounds, such as albumin, transferrin or uric
acid contribute to the antioxidant properties of saliva [31], but of special
interest here are glutathione-S-transferases which can suppress free
radicals formation. Under-expression of GSTP in ED patients is therefore
probably one element contributing to this reduced TAS. Salivary antiox-
idant properties have been previously linked to weight status, with
higher TAS in obese vs normal weight subjects [32], but the article
does not discuss the possible link with food intake. Regarding tube
feeding, it was shown to be associated with reduced acid uric in elderly
subjects [33] and in patients with neurological disorders [34] although
TAS measured by the FRAP method was not modiﬁed in the second
case. Mastication of foods has been suggested to be a source of oxidative
reactions [35,36], whichmay increase salivary TAS as a feedback mech-
anism. This would then be consistent with the ﬁnding that ED subjects
with reduced oral intake of food show lower TAS.
The second type of information relates broadly to proteolytic events
in the oral cavity of ED children. ED children tend to have a higher saliva
proteolytic activity, and also exhibit lower levels of the cysteine prote-
ase inhibitors cystatins B, D and SN, the latter ﬁnding conﬁrmed by
immunological measurement. However, no large differences were ob-
servable on free amino-acids detected by 1H NMR. Similarly, relatively
few differences were observed in peptidome proﬁles although the
majority of peptides consistently detected on MALDI–TOF spectra of
whole saliva are fragments of salivary proteins [29,37]. Finally, apart
from one possible fragment of amylase, 2D electrophoretic proﬁles did
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fore, rather than enhanced active proteolysis, the results may be
interpreted as a higher proteolytic potential (towards exogeneous
substrates for example) and a lower capacity to prevent any potential
excessive proteolysis. In the oral cavity, proteolysis may be due to
host-derived proteases but also to exogenous proteases of bacterial or
food origin. As an illustration, it was shown that cystatin SNwas present
at higher levels in saliva of infants who had started receiving solid foods
(thereby exposed to cysteine proteases of plant origin) compared to
those still on a milk-only diet [29]. Based on the poor inhibition of
endogenous cysteine proteases such as cathepsins, Dickinson [38] sug-
gested that one of the primary functions of salivary cystatins in primates
is to protect the oral cavity from dietary and environmental cysteine
proteases. Again, this is consistent with the reduced intake of food
through the oral route in ED children.
Two other identiﬁed discriminant molecules may relate to the oral
or intestinal microbial ecology. Thus, IgA1 (in its dimeric form sIgA1)
is part of the ﬁrst line of defense against pathogens in the oral cavity
[39]. However, targeted microbial assessments would be necessary to
evaluate the ecological quality of oral ﬂora in ED patients. Concerning
dimethylamine (DMA), it is one of the most commonly occurring
nitrosatable secondary amines in saliva [40]. DMA can have an endoge-
nous origin when formed from dietary choline, in a reaction catalyzed
by enzymes of gut bacteria [41,42]. Neo formed DMA is then absorbed
and secreted in various body ﬂuids including saliva [43]. Therefore, its
lower abundance in the ED group could result from alterations of the
gut microbiota consecutively to the initial pathologies of these subjects.
Indeed, it has been reported that hospitalization in neonatal intensive
care units (e.g. extremely low-birthweight infants) which is character-
ized in particular by parenteral nutrition and delayed oral feeding,
seems to affect the composition of the intestinal microbiota [44].
Finally, although this is not related to a biological function as such, it
should be pointed out that several of the identiﬁed markers in ED
patients have been previously identiﬁed as markers of sensory perfor-
mance, taste sensitivity and acceptance. For example, glutathione-S-
transferases have been immunodetected in rat taste bud cells and
the authors proposed that these may aid in maintaining the cellular
homeostasis required for proper chemoreceptive function [45]. Under-
expression of GSTP in ED patients would therefore be associated to
a lesser performance in chemosensory perception. In contrast, and
looking now at salivary proﬁles rather than at single proteins, the saliva
of adult subjects hypersensitive to the bitter taste of caffeine was char-
acterized by higher abundance of IgA, lower levels of cystatin SN and a
tendency for higher proteolytic activity [46], which corresponds to the
ﬁndings in ED patients. In three-month-old infants rejecting bitterness
(i.e. most likely hypersensitive to this taste), salivary cystatins were
under-expressedwhile two bands containing ZAGweremore abundant
[14], which is again consistent with the present results. ZAG was also
found to be over-expressed in subjects hypersensitive to the taste of
oleic acid [16]. Altogether, this shows that the salivary proﬁles of ED
patients were partly comparable to those of subjects with enhanced
gustatory sensitivity. Whether this is a factor contributing to the eating
difﬁculties developed by children after prolonged tube feeding is not
known but the topic deserves further attention.Author contributions
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